BT
Public archive
Bambusa Therapeutics plans an IPO on Nasdaq (26 Oct 2026)
Updated November 5, 2026
As of 26 October 2026, Bambusa Therapeutics plans an IPO on Nasdaq. The offer range is $15-$17.
Event data
- Company
- Bambusa Therapeutics
- Ticker
- BBTX
- Exchange
- Nasdaq
- Status
- filed
- Ipo Date
- week of October 26, 2026
- Filing Date
- 2026-10-26
- Offer Price Range
- $15-$17
- Shares Offered
- 9400000
- Amount To Raise
- $150 million
- Valuation
- $837 million (midpoint fully diluted market value)
- Underwriters
- BofA Securities, Evercore ISI, UBS Investment Bank, Cantor Fitzgerald
- Country
- United States
Subscribers saw this 8 days earlier.
Source
renaissancecapital.com